HHS Secretary Kennedy Halts $500M mRNA Vaccine Funding, Sparks Widespread Criticism

HHS Secretary Kennedy Halts $500M mRNA Vaccine Funding, Sparks Widespread Criticism

HHS Secretary Kennedy Halts $500M mRNA Vaccine Funding, Sparks Widespread Criticism

HHS Secretary Kennedy Halts $500M mRNA Vaccine Funding, Sparks Widespread Criticism
Image from NJ.com

Health and Human Services Secretary Robert F. Kennedy Jr. has ignited a storm of controversy following his department’s announcement on Tuesday, August 5, 2025, to cancel nearly $500 million in grants and contracts for mRNA vaccine projects.

The significant cutback impacts 22 projects managed by the Biomedical Advanced Research and Development Authority (BARDA), targeting the innovative mRNA technology used in vaccines for respiratory viruses like COVID-19 and the flu. This decision has immediately drawn sharp condemnation from numerous infectious disease experts, who view mRNA vaccines as safe, effective, and crucial for public health and pandemic preparedness.

Secretary Kennedy, a vocal vaccine skeptic, defended the move in a social media video, stating, “To replace the troubled mRNA programs, we’re prioritizing the development of safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don’t collapse when viruses mutate.” He asserted that the data indicated these vaccines “fail to protect effectively against upper respiratory infections.”

However, the scientific community has swiftly pushed back. Dr. Alastair McAlpine, a pediatric palliative care physician, labeled the decision “insanity,” emphasizing that “No other technology promises to provide as much protection against an array of diseases.” Dr. Jake Scott, an infectious disease specialist, countered Kennedy’s claims, asserting that abandoning this “most adaptable, scalable vaccine platform we’ve ever had” undermines future pandemic readiness.

The cancellation is the latest in a series of shifts under Secretary Kennedy’s leadership, including previous recommendations against COVID shots for healthy children and pregnant women, and the dismissal of a CDC vaccine recommendations panel. Beyond infectious diseases, mRNA technology has also shown promise in areas like cancer immunotherapies, adding another layer of concern regarding the long-term implications of this funding cut.

阅读中文版 (Read Chinese Version)

Disclaimer: This content is aggregated from public sources online. Please verify information independently. If you believe your rights have been infringed, contact us for removal.